2014
DOI: 10.2217/imt.13.175
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing NKT Cell Ligands as Vaccine Adjuvants

Abstract: NKT cells are a subpopulation of T lymphocytes with phenotypic properties of both T and NK cells and a wide range of immune effector properties. In particular, one subset of these cells, known as invariant NKT cells (iNKT cells), has attracted substantial attention because of their ability to be specifically activated by glycolipid antigens presented by a cell surface protein called CD1d. The development of synthetic α-galactosylceramides as a family of powerful glycolipid agonists for iNKT cells has led to ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
73
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(76 citation statements)
references
References 112 publications
0
73
0
3
Order By: Relevance
“…Even more, other unconventional T cell subsets may drive similar reactions, albeit in response to different stimuli and in different anatomical contexts, arguing for a general role of innate T cell subsets as natural adjuvants to promote protective immune responses. In analogy to the exploitation of iNKT cells in the clinic [193][194][195]223,224], approaches specifically targeting Vc9/Vd2 T cells may have a similar potential as vaccine adjuvant, to boost immune responses against pathogens and tumors and to modulate autoimmune responses.…”
Section: Innate Regulation Of Adaptive Immune Responses: Vd2 + Versusmentioning
confidence: 99%
“…Even more, other unconventional T cell subsets may drive similar reactions, albeit in response to different stimuli and in different anatomical contexts, arguing for a general role of innate T cell subsets as natural adjuvants to promote protective immune responses. In analogy to the exploitation of iNKT cells in the clinic [193][194][195]223,224], approaches specifically targeting Vc9/Vd2 T cells may have a similar potential as vaccine adjuvant, to boost immune responses against pathogens and tumors and to modulate autoimmune responses.…”
Section: Innate Regulation Of Adaptive Immune Responses: Vd2 + Versusmentioning
confidence: 99%
“…El azúcar en unión α es una característica importante puesto que las células de mamífero solo pueden sintetizar glicolípidos con unión β-anomérica, y esta última es muy poco estimuladora de las iNKT (5). A partir de este compuesto se han sintetizado múltiples análogos con modificaciones principalmente en el azúcar y en las colas lipídicas; el azúcar que sobresale de la molécula CD1d es uno de los principales determinantes en el reconocimiento y afinidad del TCR (6,8,26) (tabla 1).…”
Section: Antígenos Lipídicos Sintéticosunclassified
“…Un compuesto similar a este último es el llamado HS44, en el que adicionalmente se sustituye el oxígeno de unión al azúcar por un grupo amino y produce una menor respuesta de IFN-γ in vitro, pero niveles comparables in vivo con respecto a αGalCer (29). Recientemente se describió un análogo llamado 7DW8-5 (tabla 1) que ha mostrado tener una actividad mayor como adyuvante en malaria y VIH, comparado con KRN7000 (6,30).…”
Section: Antígenos Lipídicos Sintéticosunclassified
See 1 more Smart Citation
“…iNkt cells can secrete a large variety of cytokines to different glycolipid antigens presented by the CD1d molecule, which have been showed to influence the immune response in multiple infection diseases. In recent years different new glycolipid antigens has been identified, many of which have the potential to generate adjuvant effects that enhance the activity of adaptive immune cells such as dendritic cells (DCs), t cells and B cells (3,4). Moreover, for certain diseases such as tuberculosis, malaria and AIDS, it will be important to find better glycolipid adjuvants so we could improve new vaccine candidates for these public health problems (5,6).…”
Section: Introductionmentioning
confidence: 99%